- Home
- KARD vs GENI Comparison
KARD vs GENI Comparison
Compare KARD & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KARD | GENI |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Services-Misc. Amusement & Recreation |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | KARD | GENI |
|---|---|---|
| Price | $19.83 | $7.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $12.75 |
| AVG Volume (30 Days) | 266.8K | ★ 5.0M |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $24.00 |
| Revenue Next Year | N/A | $20.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.58 | $3.83 |
| 52 Week High | $27.00 | $13.73 |
Technical Indicators
Market Signals| Indicator | KARD | GENI |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 56.89 |
| Support Level | $19.71 | $5.55 |
| Resistance Level | $24.82 | $6.95 |
| Average True Range (ATR) | 1.69 | 0.40 |
| MACD | -0.20 | 0.02 |
| Stochastic Oscillator | 6.18 | 59.55 |
Price Performance
Historical ComparisonAbout KARD Kardigan Inc. Common Stock
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.